Literature DB >> 11712627

A case of relapsed tardive dyskinesia due to clozapine dose reduction.

O Uzun1, A Cansever, A Ozsahin.   

Abstract

There is no proven effective treatment for tardive dyskinesia (TD). However, clozapine has been reported to be effective in suppressing TD symptoms. In this article, we report a TD case who received clozapine. The patient recovered from TD symptoms with a dose of 450 mg/day clozapine. At the end of the first year, clozapine was decreased to a dose of 250 mg/day and TD symptoms re-emerged.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712627     DOI: 10.1097/00004850-200111000-00009

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  3 in total

Review 1.  Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.

Authors:  Joseph M Pierre
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders.

Authors:  Jocelyn Wong; Tiffanie Pang; Natalie Kwok Wing Cheuk; Yingqi Liao; Tarun Bastiampillai; Sherry Kit Wa Chan
Journal:  Psychopharmacology (Berl)       Date:  2022-09-30       Impact factor: 4.415

3.  Relapse of tardive dyskinesia due to reduction in clozapine dose.

Authors:  Meena Shrivastava; Bhupendra Solanke; Ganesh Dakhale; Abhishek Somani; Pravir Waradkar
Journal:  Indian J Pharmacol       Date:  2009-08       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.